Agilent Technologies is showing off one of its new Q-TOF mass spectrometers at the AOHUPO/PRICPS conference in Cairns this week.

Biochemical geneticist Kevin Carpenter discusses how he helped tracked down the blip in the Bindeez beads.

A collaboration between Agilent Technologies and the University of California at Davis (UCD) has developed a new way to characterise glycans in human breast milk.

Agilent Technologies has introduced the 7890A gas chromatograph (GC) platform.

Sydney researcher Adam Cawley has won the 2007 Manfred Donike prize for scientific excellence.

The power of array CGH to detect chromosomal losses and gains across the genome is sparking moves into clinical diagnostics, as Kate McDonald reports.

After a recent first-hand look, Russell McInnes shares some perspectives on India's burgeoning biotech industry.

Australia's newest research institute, the AUD$100 million Bio21 Institute, based at the University of Melbourne, officially opened its doors today.

Affymetrix is to acquire ParAllele Bioscience for about US$120 million in a deal expected to close in the third quarter of the year.

Where does the instrument end and the data begin? That question was in the air at this year's Pittcon meeting in Orlando, Florida. Equipment vendors are trying to accommodate customers who want the most direct path possible between a sample and the analysis of a sample -- even if that path leads through someone else's instrument, software or consultant.

Commercial DNA microarrays have received a strong endorsement for accuracy reproducibility of data, providing certain safeguards are met, according to a triad of newly published studies.